GENEVANT
GENEVANT
Industry:
Biopharma Health Care Life Science Medical Pharmaceutical
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Nginx Sitelinks Search Box
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-04-09 | The University of Texas Medical Branch | Genevant investment in Grant - The University of Texas Medical Branch | 35 M USD |
More informations about "Genevant"
About us - Genevant Sciences Corporation
Challenges remain, particularly with delivery. Genevant’s multiple proprietary platforms allow us to work with diverse constructs, which, combined with our track record of success in rapidly …See details»
Genevant Company Profile 2024: Valuation, Funding
Genevant General Information Description. Developer of nucleic acid drugs intended to improve the lives of people through diverse pipelines of nucleic acid-based medicines. The company utilizes lipid nanoparticle (LNP) and ligand …See details»
Our technology - Genevant Sciences Corporation
Genevant’s LNP platform is the most clinically validated in the space, with experience in more than 600 subjects across more than a dozen discrete product candidates — including in the antiviral, oncology and metabolic disorder …See details»
Genevant Sciences - The Org
Genevant is a technology-focused nucleic acid delivery company with world-class platforms, the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate and decades of expertise in nucleic acid drug development. …See details»
Genevant Sciences Corporation - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Genevant Sciences Corporation of Burnaby, BC. Get the latest business insights from Dun & Bradstreet.See details»
Genevant Sciences GmbH – Swiss Biotech
Genevant brings world-class delivery platforms that include best-in-class lipid nanoparticle (LNP) technology and next generation ligand conjugate technology, the industry’s most robust and …See details»
Epitopea and Genevant Sciences Announce Collaboration …
Dec 19, 2024 Genevant’s scientists have pioneered LNP delivery of nucleic acids for over 20 years, and Genevant’s LNP platform, which has been studied across more than a dozen …See details»
Genevant Sciences - VentureRadar
CAMBRIDGE, Mass., VANCOUVER, British Columbia, and BASEL, Switzerland, April 11, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) and Roivant …See details»
Genevant Company Profile - Office Locations, Competitors ... - Craft
Genevant offers a lipid nanoparticle (LNP) platform that enables clinical development of RNA-based therapeutics. Its proprietary ligand conjugate delivery platform has been designed for …See details»
Genevant - Crunchbase Investor Profile & Investments
Find More Contacts for Genevant. Protected Content. CTO. Executive Management 1 email found . View contacts for Genevant to access new leads and connect with decision-makers. View All Contacts . Details. Edit Details …See details»
Our team - Genevant Sciences Corporation
Tracy Meffen has served as SVP Alliance Programs & Head of QA/RA and Operations of Genevant Sciences Corporation since April 2022. Previously, she held the position Vice …See details»
Genevant, Novo Nordisk partner on gene-editing treatment for …
Nov 10, 2023 The partners will seek to advance a treatment involving gene editing — used to correct, add, or delete a DNA sequence — for the bleeding disorder. “We are thrilled to work …See details»
What is Genevant? Company Culture, Mission, Values
Glassdoor gives you an inside look at what it's like to work at Genevant, including salaries, reviews, office photos and more. This is the Genevant company profile. All content is posted …See details»
GNV-069 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 22, 2024 GNV-069, Initially developed by Genevant Sciences, Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Digestive System Disorders,Other ...See details»
Genevant Reviews: What Is It Like to Work At Genevant?
In the interest of continuous improvement, I/Genevant would like to understand your experience better. If you would be willing to speak to me, I would greatly appreciate it. If you are, please …See details»
Join us - Genevant Sciences Corporation
Genevant is that hard-to-find organization that combines a mature scientific foundation with a startup feel. Our staff brings decades of experience in nucleic acid drug delivery and …See details»
Cryptigens - Drug Targets, Indications, Patents - Synapse
Cryptigens: a Tumor-associated antigen modulators Drug, Initially developed by Genevant Sciences, Inc., Now, its global highest R&D status is Preclinical, Mechanism ...See details»
List of international organizations based in Geneva - Wikipedia
The headquarters of the International Committee of the Red Cross. Geneva hosts the highest number of international organisations in the world. [1] Palais des Nations, the main building of …See details»
HR Officer (Talent Management Suite/Analytics Officer)
Dec 19, 2024 HRD seeks to align the Office’s human resources capacity with the strategic objectives of the Organization to ensure that it can carry out its mission effectively. The …See details»
Partnering - Genevant Sciences
Collaborating selectively is an important part of our business strategy. We are especially interested in partnering with leading patient-focused pharma and biotech companies to bring …See details»